CDC Independent Valuation – 31 December 2025
CDC’s valuation increased in the quarter, supported by an additional 40MW of previously announced contracted capacity, the addition of 196MW of built operating capacity, and continued expansion of the build programme.
The 31 December 2025 independent valuation of CDC shows an increase of A$349 million since 30 September 2025, to A$14.0 billion, reflecting the mid-point of the assessed valuation range of A$13.1 billion to A$15.0 billion.
On this basis, Infratil’s 49.72% interest in CDC is valued at A$6,954 million, up A$174 million from A$6,780 million at 30 September 2025.
Further valuation details are included in the attached presentation document.
Enquiries should be directed to:
Brett Jackson
Investor Relations
Email: brett.jackson@infratil.com
Authorised for release by:
Andrew Carroll
Infratil Chief Financial Officer
Related
Australian data centre update
Infratil Limited (NZX/ASX:IFT) notes it has recently received a number of investor queries regarding power delivery timelines for under-construction sites in Australia. CDC has confirmed that it has robust delivery
Infratil Newsletter - October 2026
Attached is a copy of the latest Infratil Newsletter for investors, with commentary on our recent Investor Day and developments at various portfolio companies. Enquiries should be directed to: Brett
CDC Independent Valuation – 30 September 2026
CDC Independent Valuation – 30 September 2026 CDC’s independent valuation was broadly flat with a mid-point valuation of A$18.5 billion at 30 September 2026. Continued progress in customer contracting and